AVIA Adds Five New Members to its Network of Leading Health Systems

Tome Biosciences Launches with Over $200 Million in Funding to Advance Programmable Genomic Integration Platform

ome Biosciences, Inc., the programmable genomic integration company, has launched to usher in a new era of genomic medicines based on programmable genomic integration (PGI). PGI enables the insertion of any DNA sequence, of any size, into any programmed genomic location. The Company has raised $213 million in Series A and B funding from investors: Andreessen Horowitz (a16z) Bio + Health, ARCH Venture Partners, GV, Longwood Fund, Polaris Partners, Bruker Corporation, FUJIFILM Corporation, Alexandria Venture Investments and others.

Hyfe Unveils Next-Generation CoughPro App: Advanced Tracking and Community Features Revolutionize Chronic Cough Management

AI company transitions app to subscription model and adds exclusive new features for users in the UK, Canada, Europe and global users outside the U.S.

The ACSR Democratizes Access To Pathology Data With Proscia, Advancing Breakthroughs For HIV Cancer Patients

Distributing real-world data to researchers in hours instead of days

ENPICOM and Carterra Advance Antibody Screening by Integrating Biophysical Characterization and Repertoire Sequencing Analysis

Carterra Inc. and ENPICOM B.V. announced today a collaboration to streamline the analysis of rapidly growing sequencing and antibody screening data generated in the lab.

VLPlant™ Is Set to Revolutionize Viral Vaccine Development

BugBiome wins Discovery Spark life science programme

BugBiome announced as the winner of the Discovery Spark life science business support programme and will be awarded a business support package worth over £100,000, including one year of free lab space at Discovery Park and £50,000 investment from Discovery Park Ventures.

Ace Neuroscience Launches Drug Development Services for Stroke and Psychiatric Disorders

Amerigo Scientific's New Lab Offering: S-Silver SERS Substrates

CellNetix Selects Proscia To Deliver New Standard Of Excellence In Pathology

Modernizing the 150-year-old microscope-based practice with digital innovation

InSysBio to release public beta of fIVE Calculator

Now InSysBio presents public beta release of fIVE Calculator which is a web application designed to automatically calculate kinetic parameters from in vitro experiments for modeling of biosystems.

Abzena Partners with ProteoNic to Offer Enhanced CHO Cell Line Platform for Complex Biologics

Optibrium’s Quantum Mechanics and Machine Learning Methods Predict Routes of Drug Metabolism

Revolutionary Danish Cancer App Set for Nationwide Launch: A Milestone in Digital Healthcare

Recipharm announces collaboration with Oz-UK to accelerate the development of low global warming potential pMDIs utilising HFA-152a propellant

Hi, I hope you are well. Please see below news from Recipharm on its collaboration with CRO, Oz-UK to accelerate the development of low global warming pressurised Metered Dose Inhalers (pMDIs). It has also announced the appointment of Simon Gardner, formerly of HFA-152a propellant supplier, Koura to support customers in their transition to greener propellants. Kind regards Char

LIQUID STABLE & NIST TRACEABLE CLINICAL REFERENCE MATERIALS FOR MAGNESIUM SERUM & URINE TESTING AVAILABLE FROM VERICHEM

VERICHEM now offers calibration verification materials for the testing of both urine and serum Magnesium assays.

DoseMe Adds Cefepime to Its Model-informed Precision Dosing Platform

DoseMe today announced the availability of its Cefepime model. This model will offer pharmacokinetics and target attainment analyses to identify a rational empirical dosing strategy for Cefepime in critically ill patients, including those with unstable renal function, a common challenge faced by clinicians taking care of these complex patients.

XponentL Data Announces the Launch of a GenAI Lab within our Data and AI Center of Excellence in Kosovo

XponentL Data has announced the launch of its GenAI Lab within its Kosovo Data and AI Center of Excellence. This lab aims to accelerate innovation in Data and AI by enabling rapid testing, validation, and deployment of GenAI solutions in various sectors like healthcare, finance, and energy. Led by Elkida Bazaj, a leading AI engineer, the lab will collaborate with partners like AWS, Databricks, and Snowflake to develop practical AI applications and a use case library to enhance clients' understanding and application of GenAI technologies. The GenAI Lab will also focus on improving data quality in different business domains, starting with pharmaceutical clinical trials, leveraging large language models and generative AI.

Increased Comfort and Greater Insight with EnFocus OCT Optimized Design

Next-generation Integrated Intraoperative OCT for Proveo 8 to be Unveiled at the FLORetina ICOOR Meeting 2023

WCG Revolutionizes Ethical Review Process with IRB+ Service, Achieving Unprecedented Efficiency Gains

WCG's IRB+ service has been pressure tested on 90+ studies, ensuring that it maintains the integrity and quality of board reviews while accelerating operational processing, allowing for faster site activation and study start-up.